CYROLITE® compounds by Röhm are the world’s leading acrylic polymer developed especially for use in the Medical Device Industry. The brand was officially registered in 1977, establishing a legacy of nearly five decades of commitment to providing customers with a versatile range of medical acrylics that meet the stringent requirements of the industry.

Even with its rich history, CYROLITE® has continued to achieve notable advancements in recent years. January 2025 marks two years since the opening of the Innovation Center in Wallingford, CT – the largest non-production investment for Röhm in region Americas. As the global headquarters for medical research and development, the Innovation Center is the central hub for the development of new CYROLITE® solutions for medical devices. The team supports medical OEM for infusion therapy, blood management, diagnostics, and other technologies. Additionally, it wasn't long ago that the CYROLITE® portfolio expanded with two new products including CYROLITE® G-20 CP for superior content protection and CYROLITE® MD zk6 for enhanced impact resistance, launching at the MD&M West 2023 show.

Röhm’s CYROLITE® team takes pride in its established reputation at MD&M West over the years. This year, like always, the team eagerly anticipates meeting attendees in person and discussing how CYROLITE® can meet their application needs.